American Healthcare REIT (AHR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Dec, 2025Executive summary
Achieved a milestone with the first full year as a listed healthcare REIT, delivering strong financial and operational results in 2024, with a portfolio of 314 properties and occupancy rates between 87.5%–100%.
Reported GAAP net loss attributable to controlling interest of $(31.8) million for Q4 2024 and $(37.8) million for the full year, with net loss per diluted share of $(0.21) and $(0.29), respectively.
Normalized Funds from Operations (NFFO) per diluted share was $0.40 for Q4 and $1.41 for the year, reflecting strong operational performance.
Over $650 million invested in external growth in managed long-term care segments in 2024, with $1.36 billion raised in gross proceeds through equity offerings and ATM program.
Benefited from favorable long-term care fundamentals, driven by demographic tailwinds and limited new supply in senior housing.
Financial highlights
Total portfolio Same-Store NOI grew 21.6% year-over-year in Q4 2024 and 17.7% for the full year; consolidated cash NOI rose to $389.95M from $341.78M in FY 2023.
SHOP segment Same-Store NOI grew 66.6% in Q4 and 52.8% for the year; ISHC/Trilogy segment grew 28% in Q4 and 23.8% for the year.
Reported normalized funds from operations (NFFO) of $0.40 per diluted share in Q4 and $1.41 for full year 2024, within guidance.
Net Debt-to-Adjusted EBITDA improved from 8.5x at end of 2023 to 4.3x at end of 2024.
Adjusted EBITDA for Q4 2024 was $91.2 million.
Outlook and guidance
2025 Same-Store NOI growth guidance: 7%-10% total, 10%-12% for ISHC/Trilogy, 18%-22% for SHOP, -1% to +1% for Outpatient Medical, and -1.5% to -0.5% for Triple-Net Lease.
NFFO per share guidance for 2025: $1.56-$1.60, reflecting double-digit growth over 2024.
Net income per diluted share guidance for 2025: $0.26 to $0.30.
Expected 2025 investments: $80M–$100M in development, $86.4M in new investments in 1H25.
Guidance does not include unannounced investments; expects continued double-digit growth in managed segments.
Latest events from American Healthcare REIT
- Q3 2025 net income hit $56.6M with 16.4% NOI growth and raised 2025 guidance.AHR
Q3 202523 Apr 2026 - Double-digit NOI and FFO growth in 2025, with strong 2026 guidance and robust acquisition pipeline.AHR
Q4 202510 Apr 2026 - Proxy covers director elections, auditor ratification, and strong 2025 performance with 80% TSR.AHR
Proxy filing9 Apr 2026 - Strong demand, limited supply, and integrated care drive robust growth and operational alignment.AHR
Citi’s Miami Global Property CEO Conference 20264 Mar 2026 - Double-digit NOI growth and strong occupancy highlight robust performance and future growth potential.AHR
Investor presentation2 Mar 2026 - Strong Q2 results, raised 2024 guidance, and improved leverage driven by SHOP and ISHC growth.AHR
Q2 20242 Feb 2026 - Strong organic growth and disciplined capital allocation drive value, led by the Trilogy platform.AHR
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong NOI and revenue growth, raised guidance, and improved leverage after key acquisitions.AHR
Q3 202414 Jan 2026 - Strong multi-year growth driven by managed care, Trilogy synergies, and portfolio optimization.AHR
Citi’s 30th Annual Global Property CEO Conference 202523 Dec 2025